Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-10-19 20:31:14
Reporting Period:
Filing Date:
Accepted Time:
2016-10-19 20:31:14
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1393020 Invuity Inc. IVTY Surgical & Medical Instruments & Apparatus (3841) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576244 W Eric Roberts C/o Invuity, Inc.
444 De Haro Street
San Francisco CA 94107
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-10-17 1,000 $12.08 249,632 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 69,945 Direct
  1. The shares were sold pursuant to the Rule 10b5-1 trading plan entered into by Valence CDK SPV, L.P. ("Valence CDK") on December 1, 2015.
  2. This transaction was executed in multiple trades at prices ranging from $12.00 to $12.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The shares are held by Valence CDK. Valence Life Sciences GP II, LLC ("Valence") is the General Partner of Valence CDK. The Reporting Person is a Managing Member of Valence and disclaims beneficial ownership of the shares held by Valence CDK, except to the extent of his pecuniary interest therein.